Logomix Inc.

About:

Logomix is a biotechnology company that specializes in medication research, cell therapy, and clinical trials.

Website: https://logomix.bio/

Top Investors: JAFCO, Angel Bridge, UTokyo Innovation Platform, Sand Hill Angels, Yasunori Kaneko

Description:

Logomix is a pioneering synthetic biology company. With its unprecedented genome engineering platform, Geno-Writing™, Logomix facilitates precise and Mb-scale manipulation of genomic sequences within human cells, leads the development of super-functionalized hypoimmune cells to address critical limitations in contemporary cell therapy approaches, and unlocks the potential with a TAM of solid tumors and 70,000 genetic diseases worth trillion of dollars.